OVERVIEW

21st International Conference on Alzheimer’s Drug Discovery is organized by Alzheimer's Drug Discovery Foundation (ADDF) and will be held from Oct 05 - 06, 2020.

Description:
This annual conference will showcase the innovative approaches of Alzheimer’s Drug Discovery Foundation’s (ADDF) funded scientists and their newest results. In addition to featuring ADDF’s portfolio, the program will also include guest presentations focusing on the latest research in the Alzheimer’s disease field.

The program features five sessions:
• Novel Approaches for Neuroinflammation
• Metabolic and Mitochondrial Approaches for Alzheimer’s Disease
• Emerging Areas in Drug Development for Neurodegeneration
• Neuroprotection, Synaptic Health and Neurotransmitters
• Novel Biomarkers in Alzheimer’s Disease

Objectives:
• Highlight scientific progress on drug development and biomarker programs aimed at treating Alzheimer’s disease and related dementias.
• Increase opportunities for early career investigators and start-up companies to share information and resources.
• Foster interdisciplinary and public-private partnerships and alliances.